These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Polydatin effectively attenuates disease activity in lupus-prone mouse models by blocking ROS-mediated NET formation. Liao P; He Y; Yang F; Luo G; Zhuang J; Zhai Z; Zhuang L; Lin Z; Zheng J; Sun E Arthritis Res Ther; 2018 Nov; 20(1):254. PubMed ID: 30419963 [TBL] [Abstract][Full Text] [Related]
3. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Knight JS; Subramanian V; O'Dell AA; Yalavarthi S; Zhao W; Smith CK; Hodgin JB; Thompson PR; Kaplan MJ Ann Rheum Dis; 2015 Dec; 74(12):2199-206. PubMed ID: 25104775 [TBL] [Abstract][Full Text] [Related]
4. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Lood C; Blanco LP; Purmalek MM; Carmona-Rivera C; De Ravin SS; Smith CK; Malech HL; Ledbetter JA; Elkon KB; Kaplan MJ Nat Med; 2016 Feb; 22(2):146-53. PubMed ID: 26779811 [TBL] [Abstract][Full Text] [Related]
5. Improved Mitochondrial Metabolism and Reduced Inflammation Following Attenuation of Murine Lupus With Coenzyme Q10 Analog Idebenone. Blanco LP; Pedersen HL; Wang X; Lightfoot YL; Seto N; Carmona-Rivera C; Yu ZX; Hoffmann V; Yuen PST; Kaplan MJ Arthritis Rheumatol; 2020 Mar; 72(3):454-464. PubMed ID: 31566908 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice. Oaks Z; Winans T; Caza T; Fernandez D; Liu Y; Landas SK; Banki K; Perl A Arthritis Rheumatol; 2016 Nov; 68(11):2728-2739. PubMed ID: 27332042 [TBL] [Abstract][Full Text] [Related]
7. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin. Wang H; Li T; Chen S; Gu Y; Ye S Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802 [TBL] [Abstract][Full Text] [Related]
9. Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Targeting TLR4 and CXCL2. Yang B; Huang X; Xu S; Li L; Wu W; Dai Y; Ge MX; Yuan L; Cao W; Yang M; Wu Y; Deng D Front Immunol; 2021; 12():756825. PubMed ID: 34721432 [TBL] [Abstract][Full Text] [Related]
10. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice. Mercer JR; Yu E; Figg N; Cheng KK; Prime TA; Griffin JL; Masoodi M; Vidal-Puig A; Murphy MP; Bennett MR Free Radic Biol Med; 2012 Mar; 52(5):841-9. PubMed ID: 22210379 [TBL] [Abstract][Full Text] [Related]
11. Altered Mitochondrial Homeostasis during Systemic Lupus Erythematosus Impairs Neutrophil Extracellular Trap Formation Rendering Neutrophils Ineffective at Combating Monteith AJ; Miller JM; Williams JM; Voss K; Rathmell JC; Crofford LJ; Skaar EP J Immunol; 2022 Jan; 208(2):454-463. PubMed ID: 34930781 [TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus onset in lupus-prone B6.MRL/lpr mice Is influenced by weight gain and Is preceded by an increase in neutrophil oxidative burst activity. Toller-Kawahisa JE; Canicoba NC; Venancio VP; Kawahisa R; Antunes LM; Cunha TM; Marzocchi-Machado CM Free Radic Biol Med; 2015 Sep; 86():362-73. PubMed ID: 26117329 [TBL] [Abstract][Full Text] [Related]
13. Neutrophils in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus: Same Foe Different M.O. Fresneda Alarcon M; McLaren Z; Wright HL Front Immunol; 2021; 12():649693. PubMed ID: 33746988 [TBL] [Abstract][Full Text] [Related]
14. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production. Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF Front Immunol; 2020; 11():1047. PubMed ID: 32625200 [TBL] [Abstract][Full Text] [Related]
15. Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2. Yasuda K; Watkins AA; Kochar GS; Wilson GE; Laskow B; Richez C; Bonegio RG; Rifkin IR PLoS One; 2014; 9(7):e103478. PubMed ID: 25076492 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway. Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432 [TBL] [Abstract][Full Text] [Related]
17. Neutrophils-Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Wirestam L; Arve S; Linge P; Bengtsson AA Front Immunol; 2019; 10():2734. PubMed ID: 31824510 [TBL] [Abstract][Full Text] [Related]
18. Amelioration of nephritis in receptor for advanced glycation end-products (RAGE)-deficient lupus-prone mice through neutrophil extracellular traps. Watanabe H; Kubo M; Taniguchi A; Asano Y; Hiramatsu-Asano S; Ohashi K; Zeggar S; Katsuyama E; Katsuyama T; Sunahori-Watanabe K; Sada KE; Matsumoto Y; Yamamoto Y; Yamamoto H; Son M; Wada J Clin Immunol; 2023 May; 250():109317. PubMed ID: 37015317 [TBL] [Abstract][Full Text] [Related]